Shuzo Watanabe
Direktor/Vorstandsmitglied bei RAQUALIA PHARMA INC.
Ursprung des Netzwerks ersten Grades von Shuzo Watanabe
| Einheit | Art der Einheit | Industrie | |
|---|---|---|---|
| Public Company | Pharmaceuticals: Major | 19 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von Shuzo Watanabe
| Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
|---|---|---|---|
| Oberlin College | College/University | Undergraduate Degree | |
University of Washington
 University of Washington Other Consumer ServicesConsumer Services University of Washington functions as a College/University. The company is headquartered in Seattle, WA. | College/University | Graduate Degree | |
| SUMITOMO ELECTRIC INDUSTRIES, LTD. | Electrical Products | Director/Board Member | |
| MITSUBISHI TANABE PHARMA CORPORATION | Pharmaceuticals: Other | Chief Executive Officer | |
| TAIYO YUDEN CO., LTD. | Electronic Components | Director/Board Member | |
| TSUTSUMI JEWELRY CO.,LTD. | Specialty Stores | Director/Board Member | |
| Keio University | College/University | Graduate Degree | |
| Wagner College (New York) | College/University | Masters Business Admin | |
| MITSUBISHI CHEMICAL GROUP CORPORATION | Chemicals: Major Diversified | Director/Board Member | |
| Waseda University | College/University | Graduate Degree | |
| University of Tokyo | College/University | Doctorate Degree | |
| Rikkyo University | College/University | Undergraduate Degree | |
| Nagoya University | College/University | Undergraduate Degree | |
| Kyoto University | College/University | Doctorate Degree | |
| Tokyo Institute of Technology | College/University | Doctorate Degree | |
| Aoyama Gakuin University | College/University | Undergraduate Degree | |
JAFCO Group Co. Ltd. (Private Equity)
 JAFCO Group Co. Ltd. (Private Equity) Investment ManagersFinance JAFCO Group Co. Ltd. (JAFCO Group) is the private equity arm of the parent firm, JAFCO (TSE: 8595), founded in 1973. The firm is headquartered in Tokyo, Japan. | Investment Managers | President | |
REGiMMUNE Corp.
 REGiMMUNE Corp. Pharmaceuticals: MajorHealth Technology REGiMMUNE Corp. develops solutions for treating immune disorders. Its focus is on the discovery, development, and commercialization of immune regulatory therapeutics to treat life-threatening and debilitating conditions, including allergies, autoimmune diseases and transplantation. The firm's platform technology, reVax, induces immune tolerance in an antigen-specific manner through pharmacological induction of regulatory T (Treg) cells. It also develops products for preventing inhibitor formation in enzyme replacement therapies (ERT) and for celiac disease with undisclosed partners. The company was founded by Yasuyuki Ishii on March 3, 2006 and is headquartered in Tokyo, Japan. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| Osaka Prefecture University | College/University | Doctorate Degree | |
| Hokkaido University | College/University | Doctorate Degree | |
TMRC Co. Ltd.
 TMRC Co. Ltd. Medical/Nursing ServicesHealth Services TMRC Co. Ltd. provides contract research and manufactures medicines. It develops anti-cancer products and those for cancer associated disorders. The company was founded by Hisao Ekimoto in January 2002 and is headquartered in Tokyo, Japan. | Medical/Nursing Services | Director/Board Member Director/Board Member Director/Board Member Director/Board Member | |
| Maki Shinosuke Accounting Firm | Director/Board Member | ||
| RIBOMIC INC. | Pharmaceuticals: Major | Director/Board Member | |
| Cardio, Inc. | Director/Board Member | ||
| Tokyo University of Science | College/University | Undergraduate Degree | |
Daiwa Corporate Investment Co., Ltd.
 Daiwa Corporate Investment Co., Ltd. Investment ManagersFinance Daiwa Corporate Investment Co. Ltd. (Daiwa Corporate Investment) is a private equity arm of Daiwa Securities Group Inc. and is headquartered in Tokyo, Japan. The firm was founded in 1982. | Investment Managers | Private Equity Investor | |
The Kaiteki Institute, Inc.
 The Kaiteki Institute, Inc. Miscellaneous Commercial ServicesCommercial Services The Kaiteki Institute, Inc. engages in the research and investigation of social trends. It also involves in the research and development of new enterprises and operation and management of contract research. The company was founded on April 1, 2009 and is headquartered in Tokyo, Japan. | Miscellaneous Commercial Services | Director/Board Member | |
| Lexwell Partners | Founder | ||
Okinawa Protein Tomography Ltd.
 Okinawa Protein Tomography Ltd. Miscellaneous Commercial ServicesCommercial Services Okinawa Protein Tomography Ltd. provides polymeric molecular structure analysis services. Its technology allows imaging of macromolecules including proteins in multiple states at the single molecule-level by combining conventional electron tomography and a specifically designed 3D reconstruction program known as COMET. The firm analyzes data of molecular structures of protein samples. The company was founded by Akira Kamei on June 25, 2014 and is headquartered in Uruma, Japan. | Miscellaneous Commercial Services | Director/Board Member | |
| CxO Advisors, Inc. | Director/Board Member | ||
AskAt, Inc.
 AskAt, Inc. Pharmaceuticals: MajorHealth Technology AskAt, Inc. was founded in 2013 and is committed to optimizing the drug discovery process to deliver groundbreaking medications for pain, cancer, and dementia to patients worldwide. The company is based in Nagoya, Japan. The Japanese company's portfolio includes a focus on pain, cancer, and dementia, and their corporate philosophy and vision are centered around delivering innovative solutions to improve patient outcomes. AskAt was acquired by AskAat, Inc. /Yoshida/ from RaQualia Pharma, Inc. on May 14, 2015. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer President | |
| PCI HOLDINGS, INC. | Information Technology Services | Director/Board Member | |
| FUNPEP COMPANY LIMITED | Biotechnology | Founder | |
77 Capital KK
 77 Capital KK Investment ManagersFinance 77 Capital KK (77 Capital) is a Venture Capital firm, a subsidiary of The 77 Bank, Ltd. (TK:8341) founded in 2016. The firm is headquartered in Sendai. | Investment Managers | Director/Board Member | |
| CHORDIA THERAPEUTICS INC. | Pharmaceuticals: Major | Director/Board Member | |
| RaQualia Innovations, Inc. | Director/Board Member | ||
| TSUBOTA LABORATORY INCORPORATED | Miscellaneous Commercial Services | Director/Board Member | |
| MSPG Consulting KK | President | ||
| MS Partners | Director/Board Member | ||
| Kagoshima Pro Sports Project Co. Ltd. | Comptroller/Controller/Auditor |
Statistik
International
| Japan | 38 |
| Vereinigte Staaten | 5 |
Sektoral
| Consumer Services | 15 |
| Health Technology | 7 |
| Finance | 5 |
| Commercial Services | 4 |
| Producer Manufacturing | 2 |
Operativ
| Director/Board Member | 44 |
| Independent Dir/Board Member | 11 |
| Corporate Officer/Principal | 7 |
| Comptroller/Controller/Auditor | 5 |
| President | 5 |
Am stärksten vernetzte Beziehungen
- Börse
- Insiders
- Shuzo Watanabe
- Unternehmensverbindungen
